Singulus Technologies Aktiengesellschaft: SINGULUS TECHNOLOGIES Receives Significant Order for Medical Technology

Kahl am Main (pta014/04.08.2021/12:15 UTC+2)

Disclosure of Insider Information Pursuant to Art. 17 MAR

SINGULUS TECHNOLOGIES Receives Significant Order for Medical Technology

Kahl am Main, 04 August 2021 - The SINGULUS TECHNOLOGIES AG (SINGULUS TECHNOLOGIES) has received a significant order for the delivery of several new processing machines from an internationally operating customer in the medical sector. The order volume is in a low double-digit € range. The prepayment for this order is expected to be received shortly.

After the successful installation of machines of the MEDLINE type for a site in Asia, this is the continuation of the cooperation and further development of the MEDLINE. The processing machine by SINGULUS TECHNOLOGIES cleans contact lenses from residues and subsequently coats the lenses in the course of an additional processing step. 

For Medical Technology, in addition to the production machines for wet-chemical processes, SINGULUS TECHNOLOGIES also offers processes applying vacuum coating technology and positioned its processes to meet the international requirements and regulations (GMP - "Good Manufacturing Practice") as well as the high demands of the medical sector. 

SINGULUS TECHNOLOGIES AG, Hanauer Landstrasse 103, 
D-63796 Kahl/Main, WKN A1681X / ISIN DE000A1681X5

Contact: 

Maren Schuster, Investor Relations, Tel.: + 49 (0) 160 9609 0279

Bernhard Krause, Corporate Communications, Tel.: +49 (0) 172 833 2224

Email: bernhard.krause@singulus.de

(end)

Emitter:	Singulus Technologies Aktiengesellschaft Hanauer Landstraße 103 63796 Kahl am Main Germany
Contact Person:	Bernhard Krause
Phone:	+49 170 9202924
E-Mail:	bernhard.krause@singulus.de
Website:	www.singulus.de
ISIN(s):	DE000A1681X5 (Share) DE000A2AA5H5 (Bond)
Stock Exchange(s):	Regulated Market in Berlin, Frankfurt; Free Market in Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate